Medtech
New Zealand has approved MDMA for treating severe PTSD, becoming the second country after Australia to permit its use for the condition. The approval was granted by New Zealand's pharmaceutical regulator, Medsafe, and follows Australia's 2023 decision to approve psychedelics for PTSD and treatment-resistant depression. Two psychiatrists have been authorised to prescribe pharmaceutical-grade [...]
Elekta has secured a loan of up to €100m to support a roughly €200m research programme focused on cancer and neurological treatment technologies. The Stockholm-based medical technology company plans to carry out the research programme between 2026 and 2029, with most of the work based in Sweden and the Netherlands. The financing will support work [...]
London surgeons have performed what health officials described as the first successful AI-assisted brain tumour operation, helping save a patient's sight. The surgery was carried out in May on 48-year-old Rhys Hibbert, who had an 11mm tumour on his pituitary gland and faced losing his sight without an operation, health officials said. During the procedure, [...]
Health tech start-up Souuthe has secured £75,000 to develop dementia tech for people living with dementia and receiving palliative care. The Saltburn-by-the-Sea business has been awarded an Innovate UK Women in Innovation Award, with founder Lou Willis-Keeler selected as one of 61 entrepreneurs from a record 1,590 applicants nationwide. The business is developing calming technology [...]
KKR will take Integer Holdings private in an all-cash US$5.7bn deal, expanding its healthcare portfolio with the medical device supplier. Shares in the Plano, Texas-based company rose 2.6 per cent in early trading. Integer makes components and finished products used by medical device companies in cardiovascular and neuromodulation therapies, among other applications. [...]
Geneva-based HeroSupport has announced that NYU Grossman School of Medicine is the first US clinical site in its SHIELD study of VENUS SHELL. Professor Naamit Gerber will serve as principal investigator. Gerber is professor and vice-chair of education in the department of radiation oncology at NYU Grossman School of Medicine. She is [...]
Around 6,600 people in England will gain access to the drug aficamten following simultaneous MHRA authorisation and NICE approval. The once-daily tablet, also known as MYQORZO, is for people with symptomatic obstructive hypertrophic cardiomyopathy. Known as obstructive HCM, the condition causes the heart muscle to become thick and stiff, making it harder to pump blood [...]
By Kieran Killough, partner, HGF Limited For many years, medical device companies operated in a regulatory environment where significant product and compliance information was held within national systems and was therefore difficult for competitors to access. The European Database on Medical Devices (EUDAMED) changes that landscape. Developed under the EU Medical Device Regulation (MDR) and [...]
By Yaqi Xie, co-founder, Neurotact Why developing novel medtech extends beyond the technology itself When we talk about progress in medtech, we often think of visible milestones: securing funding, beginning clinical studies, obtaining regulatory approval or reaching the market. These are important achievements, but they capture only part of what it takes [...]
Xeltis has raised an additional €20.5m to expand its vascular implant programmes in Europe and the US. The commercial-stage medtech company, based in the Netherlands and the US, develops artificial vessels and valves that are gradually replaced by patients’ own healthy tissue. Its Restorex platform uses an advanced polymer implant that is transformed into the [...]
